Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 265-449-9 | CAS number: 65113-55-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- from 2011-12-06 to 2011-12-27
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2012
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
Test material
- Reference substance name:
- [4-[p,p'-bis(dimethylamino)benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium m-[[p-anilinophenyl]azo]benzenesulphonate
- EC Number:
- 265-449-9
- EC Name:
- [4-[p,p'-bis(dimethylamino)benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium m-[[p-anilinophenyl]azo]benzenesulphonate
- Cas Number:
- 65113-55-5
- Molecular formula:
- C25H30N3.C18H14N3O3S
- IUPAC Name:
- [4-[p,p'-bis(dimethylamino)benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium m-[[p-anilinophenyl]azo]benzenesulphonate
- Test material form:
- solid: particulate/powder
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: elevage JANVIER (53940 Le Genest St Isle - FRANCE)
- Age at study initiation:8 weeks old
- Weight at study initiation: between 181 g and 199 g
- Fasting period before study: Drinking water (tap water from public distribution system) and foodstuff (M20, SDS) were supplied freely. Food was removed at D-1 and then redistributed 4 hours after the test item administration
- Housing: Animal were housed by group of 3 in solid-bottomed clear polycarbonate cages with a stainless steel mesh lid. Cage was installated in conventional air conditioned animal husbandry
- Diet (e.g. ad libitum): Ad libitum.
- Water (e.g. ad libitum):Ad libitum
- Acclimation period: At least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 to 25°C
- Humidity (%): 30 to 70%
- Air changes (per hr): approximately 15 changes per hour
- Photoperiod (hrs dark / hrs light): 12h dark/12h light
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- olive oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: adapted for each animals
- Amount of vehicle (if gavage): 10 mL/kg
- Justification for choice of vehicle: Olive oil was chosen among various vehicules because it does not induce pain. It has been chosen since it allowed to prepare a homogenous mixture, under stirring, usable for oral administration
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: Based on previous examination of similar molecules, the dose of 2000 mg/kg was chosen. - Doses:
- The 2 treated groups were dosed at 2000 mg/kg body weight
- No. of animals per sex per dose:
- 3 females/dose/step:
STEP 1: 3 females at 2000 mg/kg body weight (N° Rf 9009, 9010 and 9011)
STEP 2: 3 females at 2000 mg/kg body weight (N° Rf 9048, 9049 and 9050) - Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Daily observations (spontaneous activity, preyer's reflex, respiratory rate, convulsions, tremors, body temperature, muscle tone, palpebral opening, pupil appearance, salivation, lachrymation, righting reflex, back hair appearance) and weighing on days D0 (before administration), D2, D7 and D14.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,organ weights, histopathology, other: Macroscopic examinations at the end of the study (after anaesthesia) with the examination of organs likely to be modified in cases of acute toxicity (i.e. oesophagus, stomach, the entire digestif tract, spleen, liver, thymus, trachea, lungs, heart, kidneys, urinary bladder, ovaries, uterus, treatment area, adrenals, pancreas).
Results and discussion
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality occured during the study
- Clinical signs:
- other: At T0 + 1 hour: STEP 1: blue faeces in all the treated animals / STEP 2: Rf 9049 and 9050 = blue faeces. Rf 9048 = decrease in spontaneous activity. At T0 + 3 and 4 hours: Blue faeces in all the treated animals in both step. D1 to D10: STEP 1: blue fae
- Gross pathology:
- The macroscopical examination of the animals at the end of the study revealed a white thickening of the forestomach in all the treated animals of the STEP 2.
No other observations or abnormalities were to report.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The LD50 of the test item is higher than 2000 mg/kg body weight by oral route in the rat.
In accordance with the OECD guideline N° 423, the LD50 cut-off of the test item may be considered to be higher than 2000 mg/kg body weight by oral route in the rat.
According to the classification, packaging and labelling of dangerous substances and preparations in accordance with the EEC directives 67/548, 2011/59 and 99/45, the test item must not be classified. No symbol or risk phrase is required.
In accordance with the regulation EC N° 1272/2008 on classification, labelling and packaging of substances and mixtures, the test item must not be classified. No signal word or hazard statement is required. - Executive summary:
The test item was administered to a group of 6 female Sprague Dawley rats at the single dose of 2000 mg/kg body weight. The experimental protocol was established according to the official method as defined in the OECD guideline N° 423 dated December 17th, 2001 and the test method B.1tris of the Council regulation N°440/2008.
No mortality occured during the study.
From the first day of the test, decrease in spontaneous activity (3/6) and blue faeces (6/6) were observed. The animals recovered a normal spontaneous activity on day 1 (2/3) and on day 10 (1/3), and recovered normal faeces on day 11 (3/6) and on day 13 (3/6).
A decrease in body weight of two animals (2/6) was noted on day 7: between -9% and -19% compared to day 0.
The macroscopical examination of the animals at the end of the study revealed a white thickening of the forestomach (3/6).
In conclusion, the LD50 of the test item is higher than 2000 mg/kg body weight by oral route in the rat.
In accordance with the OECD guideline N° 423, the LD50 cut-off of the test item may be considered to be higher than 2000 mg/kg body weight by oral route in the rat.
According to the classification, packaging and labelling of dangerous substances and preparations in accordance with the EEC directives 67/548, 2011/59 and 99/45, the test item Solvent Black 46 must not be classified. No symbol or risk phrase is required.
In accordance with the regulation EC N° 1272/2008 on classification, labelling and packaging of substances and mixtures, the test item must not be classified. No signal word or hazard statement is required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.